Sevelamer Carbonate For Oral Suspension

Hangzhou Anprime Biopharm Co., Ltd.🇺🇸 United States

FDA Page

Effective Date: Mar 24, 2023
Approval ID: 8ef0cb12-e9f6-4865-9158-02c8cc50a511
Products: 2 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspensionInitial U.S. Approval: 2000

Quick Stats

Total Products2

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.